￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
LUCENT-3: Mirikizumab benefits sustained for 4 years in ulcerative colitis

2026-02-01 22:25:32

Check Details
Nerandomilast-Jascayd instruction manual in Chinese

2026-02-01 22:25:32

Check Details
Are there generic options for selumetinib?

2026-02-01 22:25:32

Check Details
How to deal with common side effects of Lorlatinib/lorlatinib (Borina)

2026-02-01 22:25:32

Check Details
Why is cabozantinib not recommended?

2026-02-01 22:25:32

Check Details
Is Bosutinib a second- or third-generation drug?

2026-02-01 22:25:32

Check Details
What side effects of nintedanib/Vigat should patients be cautious about?

2026-02-01 22:25:32

Check Details
The effects and efficacy of Nerandomilast-Jascayd

2026-02-01 22:25:32

Check Details
Pomalidomide price in 2025

2026-02-01 22:25:32

Check Details
Why is Lapatinib/Talisa ineffective in patients with breast cancer?

2026-02-01 22:25:32

Check Details
What are the specific effects of filgotinib?

2026-02-01 22:25:32

Check Details
How much does a box of Trientine cost?

2026-02-01 22:25:32

Check Details
Category
相关知识